What Researchers Did
The researchers reviewed the medical charts of patients with sudden hearing loss of unknown cause who had hyperbaric oxygen therapy, and checked whether hearing changes after the first week could predict the final result.
What They Found
In this retrospective chart review of 39 patients with idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen, a negative early response after the first week was the only significant predictor of treatment failure, with an odds ratio of 6.98 (95% confidence interval 1.59 to 30.61, p equal to 0.010). A negative early response meant that average hearing level had not improved by at least 10 decibels. After the first week, 18 patients (46.2%) had a negative early response. At the end of treatment, hearing improvement was very substantial (20 decibels or more) in 21 patients (53.8%), substantial (10 to 19 decibels) in eight (20.5%), minimal in five (12.8%) and absent in five (12.8%).
What This Means for Canadian Patients
For people with sudden hearing loss of unknown cause, this study suggests that hearing results after the first week of hyperbaric oxygen sessions were linked to how the treatment ended up. About half of the patients had a negative early response, and the authors found that those patients were less likely to benefit from additional sessions. The study had no comparison group, so it cannot show how much of the hearing change was due to the therapy itself.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective chart review of only 39 patients with no comparison group, and the authors state that further prospective studies are necessary to confirm the findings.